Heparin as a pharmacologic intervention to induce positive scintiscan in occult gastrointestinal bleeding
Journal Article
·
· Clin. Nucl. Med.; (United States)
The value of using heparin as a pharmacologic intervention to induce a positive scintiscan was studied in a patient with chronic occult gastrointestinal bleeding. When all standard diagnostic tests (upper and lower gastrointestinal series, upper and lower endoscopy, and conventional noninterventional Tc-99m RBC imaging) fail to detect and localize gastrointestinal bleeding in a patient who has definite clinical evidence (guaiac positive stool and dropping hemoglobin, hematocrit) of chronic occult gastrointestinal oozing, heparin may be used (with proper precaution) as a last resort to aid in the scintigraphic detection and localization of chronic occult gastrointestinal bleeding.
- Research Organization:
- VA Medical Center, Hampton, VA
- OSTI ID:
- 6630437
- Journal Information:
- Clin. Nucl. Med.; (United States), Journal Name: Clin. Nucl. Med.; (United States) Vol. 9:4; ISSN CNMED
- Country of Publication:
- United States
- Language:
- English
Similar Records
Detection of gastrointestinal bleeding by radionuclide scintigraphy
Detection of gastrointestinal bleeding with /sup 99m/Tc-labeled red blood cells
Evaluation of technetium-99m DTPA for localization of site of acute upper gastrointestinal bleeding
Journal Article
·
Sat Dec 31 23:00:00 EST 1983
· Am. J. Gastroenterol.; (United States)
·
OSTI ID:6413339
Detection of gastrointestinal bleeding with /sup 99m/Tc-labeled red blood cells
Journal Article
·
Wed Mar 31 23:00:00 EST 1982
· Semin. Nucl. Med.; (United States)
·
OSTI ID:7070685
Evaluation of technetium-99m DTPA for localization of site of acute upper gastrointestinal bleeding
Journal Article
·
Fri Oct 31 23:00:00 EST 1986
· Clin. Nucl. Med.; (United States)
·
OSTI ID:6857336
Related Subjects
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANTICOAGULANTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CARBOHYDRATES
COUNTING TECHNIQUES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DRUGS
ERYTHROCYTES
GASTROINTESTINAL TRACT
HEMATOLOGIC AGENTS
HEMORRHAGE
HEPARIN
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLING
MATERIALS
MUCOPOLYSACCHARIDES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC SULFUR COMPOUNDS
PATHOLOGICAL CHANGES
PATIENTS
POLYSACCHARIDES
RADIOISOTOPE SCANNING
RADIOISOTOPES
SACCHARIDES
SCINTISCANNING
SYMPTOMS
TECHNETIUM 99
TECHNETIUM ISOTOPES
UPTAKE
YEARS LIVING RADIOISOTOPES
62 RADIOLOGY AND NUCLEAR MEDICINE
AMINES
ANTICOAGULANTS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BIOLOGICAL MATERIALS
BLOOD
BLOOD CELLS
BODY FLUIDS
CARBOHYDRATES
COUNTING TECHNIQUES
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DIGESTIVE SYSTEM
DRUGS
ERYTHROCYTES
GASTROINTESTINAL TRACT
HEMATOLOGIC AGENTS
HEMORRHAGE
HEPARIN
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
ISOMERIC NUCLEI
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLING
MATERIALS
MUCOPOLYSACCHARIDES
NUCLEI
ODD-EVEN NUCLEI
ORGANIC COMPOUNDS
ORGANIC SULFUR COMPOUNDS
PATHOLOGICAL CHANGES
PATIENTS
POLYSACCHARIDES
RADIOISOTOPE SCANNING
RADIOISOTOPES
SACCHARIDES
SCINTISCANNING
SYMPTOMS
TECHNETIUM 99
TECHNETIUM ISOTOPES
UPTAKE
YEARS LIVING RADIOISOTOPES